Abstract P3-05-13: Overexpression of insulin receptor substrate 4 can mediate acquired resistance to lapatinib-containing regimens in HER2+ breast cancer cellsLanfang Qin, Rachel Schiff, Huizhong Hu et al.|Cancer Research|2015Cited by 1